Postmenopausal hormone therapy: The way ahead

Maturitas

Volumn 57, Issue 1, 2007, Pages 3-5

  Pines, Amos ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Benefits; Hormones; Media; Menopause; Risks

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DROSPIRENONE; ESTRADIOL; ESTROGEN; GESTAGEN; HORMONE; INSULIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THYROID HORMONE;

AGE DISTRIBUTION; AGING; ARTICLE; BLOOD PRESSURE REGULATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; GENE MAPPING; HORMONE SUBSTITUTION; HUMAN; MEDICAL EDUCATION; MENOPAUSAL SYNDROME; MOLECULAR BIOLOGY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PERIPHERAL EDEMA; POSTMENOPAUSE; PROGNOSIS; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT PLANNING;

CLINICAL TRIALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; RISK; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 34247123120     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.001     Document Type: Article

References (10)

1. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits from the women's Health Initiative in healthy postmenopausal women. JAMA 288 (2002) 321-333
3. U.S. Preventive Services Task Force. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med 142 (2005) 855-860
4. Grady D. Management of menopausal symptoms. N Engl J Med 355 (2006) 2338-2347
5. Manson J.E., Bassuk S.S., Herman S.M., et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 13 (2006) 139-147
6. Lobo R. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk. Maturitas 51 (2005) 98-109
7. Pines A. WHI and aftermath: looking beyond the figures. Maturitas 51 (2005) 48-50
8. Hsia J., Langer R.D., Manson J.E., et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 166 (2006) 357-365
9. Stefanick M.L., Anderson G.L., Margolis K.L., et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295 (2006) 1647-1657
10. Nabel E.G. The Women's Health Initiative. Science 313 (2006) 1703